Publicacions en col·laboració amb investigadors/es de Hospital Clinico Universitario de Valencia (11)

2017

  1. Oxidative imbalance in low/intermediate-1-risk myelodysplastic syndrome patients: The influence of iron overload

    Clinical Biochemistry, Vol. 50, Núm. 16-17, pp. 911-917

  2. Patients with chronic lymphocytic leukemia and complex karyotype show an adverse outcome even in absence of TP53/ATM FISH deletions

    Oncotarget, Vol. 8, Núm. 33, pp. 54297-54303

2015

  1. Fluorescence in situ hybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia

    Leukemia and Lymphoma

2013

  1. Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does -7/7q- detection by FISH have prognostic value?

    Leukemia Research, Vol. 37, Núm. 4, pp. 416-421

  2. Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: Analysis of 627 patients with isolated 13q deletion

    British Journal of Haematology, Vol. 163, Núm. 1, pp. 47-54

  3. Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia

    Blood, Vol. 122, Núm. 24, pp. 3951-3959

2011

  1. Cytogenetic risk stratification in chronic myelomonocytic leukemia

    Haematologica, Vol. 96, Núm. 3, pp. 375-383

1990

  1. Evaluation von 196 patienten mit chronischer myeloischer leukämie anhand eines standard-prognose-modells

    Oncology Research and Treatment, Vol. 13, Núm. 2, pp. 109-114

1988

  1. Study of toxicity and haemopoietic recovery induced by adjuvant chemotherapy in patients with breast neoplasms

    Sangre, Vol. 33, Núm. 3, pp. 171-177

1987

  1. Intratumoral variations in cytoplasmic estrogen receptor levels in breast cancer

    Breast Cancer Research and Treatment, Vol. 9, Núm. 1, pp. 69-70

1986

  1. Treatment results of nine patients with burkitt's lymphoma

    Blut, Vol. 53, Núm. 4, pp. 279-286